| Recruiting | Cancer Loyalty Card Study 2 (CLOCS-2) NCT06447064 | Imperial College London | — |
| Not Yet Recruiting | Prognostic Role of molEcular classiFication in Fertility-sparing treAtment of Endometrial canCEr NCT06799624 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | — |
| Recruiting | Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer NCT06795009 | Washington University School of Medicine | Phase 1 |
| Recruiting | Molecular and Cellular Profiling of Uterine Lavage Collected During Gynecologic Surgery NCT07044505 | Stanford University | N/A |
| Enrolling By Invitation | Initial Testing of a Behavioral Intervention About Genetic Services for Families at Risk of Lynch Syndrome NCT07106359 | University of Alabama at Birmingham | N/A |
| Recruiting | Sample Collection for Ongoing Research and Product Evaluation Study NCT07318051 | Natera, Inc. | — |
| Recruiting | Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women NCT06904365 | Washington University School of Medicine | — |
| Recruiting | Azenosertib in Uterine Serous Carcinoma: Biomarker Study NCT06369155 | Joyce Liu, MD | Phase 2 |
| Completed | GYNecologic Cancer-Related COGnitive Impairment NCT06662435 | Northwestern University | N/A |
| Recruiting | Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin NCT06677190 | Dana-Farber Cancer Institute | Phase 2 |
| Recruiting | Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology NCT06392997 | ZIWIG | — |
| Completed | Enhanced Assistance During Radiotherapy for Unmet Essential Needs NCT06582849 | Washington University School of Medicine | N/A |
| Not Yet Recruiting | Insights Into Participating in Studies for Uterine Cancer NCT05998811 | Power Life Sciences Inc. | — |
| Recruiting | Investigations of Reproductive Cancers in Women NCT06527157 | PinkDx, Inc. | — |
| Recruiting | [18F]FES PET/.CT in Uterine Cancer NCT05916196 | Abramson Cancer Center at Penn Medicine | Phase 2 |
| Recruiting | Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy NCT06024109 | Aesculap AG | — |
| Recruiting | Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking NCT05977621 | Duke University | — |
| Recruiting | PROton Therapy for Post Surgical Treatment of GYNecologic Cancer NCT05758688 | Abramson Cancer Center at Penn Medicine | Phase 2 |
| Recruiting | Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy NCT05990426 | Northwestern University | N/A |
| Recruiting | Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment) NCT05743517 | Northwestern University | N/A |
| Recruiting | Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma NCT05559879 | University of Alabama at Birmingham | Phase 1 / Phase 2 |
| Unknown | A Retrospective Study on Multiple Classifier Endometrial Cancer NCT05976113 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | — |
| Completed | Study of a Rapid Triadic Communication Intention Elicitation Intervention to Improve Supportive Oncology Care NCT05995860 | Indiana University | N/A |
| Active Not Recruiting | A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid NCT05864144 | Sensei Biotherapeutics, Inc. | Phase 1 / Phase 2 |
| Unknown | Adherence and Compliance to ERAS in Gynecological Surgery NCT05738902 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | — |
| Unknown | A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (V NCT05708950 | Kineta Inc. | Phase 1 / Phase 2 |
| Completed | Prolonged Grief and Perception of Femininity in Gynecological Cancer Patients NCT05529303 | Kevser Pamuk | N/A |
| Recruiting | Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) NCT05579366 | Genmab | Phase 1 / Phase 2 |
| Recruiting | NYSCF Scientific Discovery Biobank NCT06203106 | New York Stem Cell Foundation Research Institute | — |
| Withdrawn | SIGNAL:Identifying Behavioral Anomalies Using Smartphones to Improve Cancer Care NCT04368130 | Dana-Farber Cancer Institute | N/A |
| Completed | Interventions to Decrease Financial Toxicity NCT05939440 | University of Alabama at Birmingham | N/A |
| Completed | Connecting Audio and Radio Sensing Systems to Improve Care at Home NCT05344950 | UNC Lineberger Comprehensive Cancer Center | — |
| Enrolling By Invitation | Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies NCT03762733 | National Cancer Institute (NCI) | — |
| Completed | The Registry of Oncology Outcomes Associated With Testing and Treatment NCT04028479 | Taproot Health | — |
| Completed | PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers NCT05697198 | Labcorp Corporation of America Holdings, Inc | — |
| Recruiting | Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genito NCT04038619 | M.D. Anderson Cancer Center | Phase 1 |
| Active Not Recruiting | Radiomics and Molecular Classification in Endometrial Cancer NCT06963385 | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | N/A |
| Completed | Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients NCT04604158 | Gillian Gresham | N/A |
| Completed | Feasibility Testing of Patient Reported Outcomes - Informed Symptom Management System (PRISMS) NCT04492007 | UNC Lineberger Comprehensive Cancer Center | N/A |
| Completed | Neo-adjuvant Pembrolizumab in dMMR/ POLE-EDM Uterine Cancer Patients: a Feasibility Study NCT04262089 | University Medical Center Groningen | Phase 1 |
| Terminated | Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors NCT04383210 | Elevation Oncology | Phase 2 |
| Terminated | A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors NCT04424641 | Genmab | Phase 1 / Phase 2 |
| Active Not Recruiting | Journey Ahead: Enhancing Coping and Communication for Women Diagnosed With Gynecological Cancer NCT05220033 | Rutgers, The State University of New Jersey | N/A |
| Unknown | Effect of Hemp-CBD on Patients With CIPN NCT04398446 | Main Line Health | Phase 2 |
| Completed | Gynecologic Brachytherapy-Specific Educational Video NCT04363957 | University of California, San Diego | N/A |
| Completed | Effects of Centering Pre-operative Counseling on Patient Reported Anxiety NCT04068675 | Northwestern University | N/A |
| Terminated | Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures NCT04849858 | University of California, Irvine | Phase 3 |
| Unknown | MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour NCT03934827 | Imperial College London | Phase 1 |
| Unknown | Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients NCT03924466 | Universitair Ziekenhuis Brussel | Phase 2 |
| Terminated | Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer NCT03694834 | UNC Lineberger Comprehensive Cancer Center | EARLY_Phase 1 |
| Unknown | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor NCT03896958 | SpeciCare | — |
| Unknown | Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and U NCT04239443 | Hunan Cancer Hospital | Phase 2 |
| Recruiting | Study of NEO-201 in Solid Tumors Expansion Cohorts NCT03476681 | Precision Biologics, Inc | Phase 1 / Phase 2 |
| Terminated | Pilot Study to Assess the Potential Clinical Utility of 18F Fluciclovine PET for Cervical and Endometrial Canc NCT03423082 | Nghi Nguyen | Phase 4 |
| Active Not Recruiting | AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma NCT03668340 | Dana-Farber Cancer Institute | Phase 2 |
| Completed | Effect of Anesthetic Agents on Optic Nerve Sheath Diameter NCT03701529 | Hallym University Kangnam Sacred Heart Hospital | N/A |
| Completed | Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors NCT03662204 | Exact Sciences Corporation | — |
| Completed | Anxiety and Distress Levels in Women With Suspected Endometrial Cancer NCT03813719 | Imperial College London | — |
| Withdrawn | Rapid First Contact Using Virtual Visits to Improve Time-To-Treatment for Uterine Cancer NCT03583736 | Case Comprehensive Cancer Center | N/A |
| Completed | Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers NCT03604653 | Holy Name Medical Center, Inc. | — |
| Completed | A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial End NCT03395080 | Leap Therapeutics, Inc. | Phase 2 |
| Completed | Recalling the Treatment and Prognosis of Upper Tract Urothelial Cancer (UTUC) NCT06401265 | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation | — |
| Completed | Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA NCT03285802 | Greater Baltimore Medical Center | Phase 2 / Phase 3 |
| Recruiting | Liquid Biopsy Evaluation and Repository Development at Princess Margaret NCT03702309 | University Health Network, Toronto | — |
| Completed | A Study of Nivolumab in Selected Uterine Cancer Patients NCT03241745 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer NCT03192059 | University Hospital, Ghent | Phase 2 |
| Completed | A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers NCT03073525 | Gradalis, Inc. | Phase 2 |
| Recruiting | Image-Guided Gynecologic Brachytherapy NCT02993900 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | N/A |
| Unknown | Laser Fluorescence in Cancer Surgical Treatment NCT03021200 | Instituto do Cancer do Estado de São Paulo | N/A |
| Completed | Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers NCT02725489 | Mary Crowley Medical Research Center | Phase 2 |
| Completed | The Effects of Perioperative Dexmedetomidine Administration on Immune Suppression and Outcomes in Patients Wit NCT02896413 | Yonsei University | N/A |
| Unknown | Efficacy of the Standard Treatment and Fusion Ontogenetic Surgery for Gynecologic Cancers NCT02986568 | Seoul National University Hospital | N/A |
| Completed | MR-HIFU for Recurrent Gynaecological Cancer NCT02714621 | Institute of Cancer Research, United Kingdom | N/A |
| Completed | A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification NCT02209532 | Novadaq Technologies ULC, now a part of Stryker | N/A |
| Completed | A Mind-body Intervention to Improve Body and/or Self Image NCT02531997 | University of Michigan | N/A |
| Unknown | Efficacy of Pelvic Autonomic Nerve Monitoring System (PAMS I) in Female Patients With Pelvic Tumors NCT02952183 | Seoul National University Hospital | N/A |
| Unknown | Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer NCT02458001 | University College, London | N/A |
| Completed | Pillars4Life Trial NCT02465892 | Duke University | N/A |
| Completed | Ensuring Communication in Hospice by Oncology Study (ECHO) NCT02069769 | Massachusetts General Hospital | N/A |
| Completed | Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates. NCT01953107 | Sunnybrook Health Sciences Centre | Phase 4 |
| Completed | Proton Beam Teletherapy for Post-Hysterectomy Cancers of the Uterus and Cervix NCT01600040 | Massachusetts General Hospital | N/A |
| Completed | Strength Training Study for Survivors of Breast and Gynecologic Cancer NCT01709175 | Nova Scotia Health Authority | N/A |
| Unknown | Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer NCT01650376 | Swedish Medical Center | Phase 1 / Phase 2 |
| Completed | Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy NCT01601548 | Masonic Cancer Center, University of Minnesota | N/A |
| Completed | Intravenous or Intra-abdominal Local Anesthetics for Postoperative Pain Management. NCT01492179 | Örebro University, Sweden | Phase 4 |
| Completed | Assisted Exercise in Obese Endometrial Cancer Patients NCT01870947 | Case Comprehensive Cancer Center | N/A |
| Completed | Image-Guided Gynecologic Brachytherapy NCT01399658 | Dana-Farber Cancer Institute | Phase 2 |
| Completed | Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting NCT01432015 | Gynecologic Oncology Associates | Phase 4 |
| Completed | Pelvic Floor Disorders in Survivors of Gynecologic Malignancies NCT01370122 | Abramson Cancer Center at Penn Medicine | — |
| Withdrawn | A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in S NCT01176500 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity NCT01163552 | St. Luke's-Roosevelt Hospital Center | Phase 2 |
| Terminated | The Effect of Guided Imagery and Music Therapy on Post-Operative Recovery After Gynecological Oncology Surgery NCT01284075 | University of Minnesota | N/A |
| Completed | Musicotherapy in the Reduction of Fatigue in Women With Breast or Gynecological Cancer Under Radiotherapy NCT01570218 | Universidade Federal de Goias | N/A |
| Completed | The Effect of Nutritional Counseling for Cancer Patients NCT01962272 | University of Copenhagen | Phase 4 |
| Completed | Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema NCT00944944 | Memorial Sloan Kettering Cancer Center | — |
| Completed | Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health NCT00870233 | Memorial Sloan Kettering Cancer Center | — |
| Terminated | Comparison of Standard of Care or Treatment on Protocol NCT01010334 | New Mexico Cancer Research Alliance | N/A |
| Completed | Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hyste NCT00746018 | Memorial Sloan Kettering Cancer Center | N/A |
| Completed | A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survi NCT00706875 | Memorial Sloan Kettering Cancer Center | — |
| Terminated | Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix NCT00626561 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | Feasibility Study: Accuracy of Biomarker in Detection of Endometrial Cancer NCT00471120 | Dick Domanik | N/A |
| Unknown | Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy NCT02349958 | Bay Area Gynecology Oncology | Phase 2 |
| Completed | Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance NCT00581646 | Memorial Sloan Kettering Cancer Center | — |
| Terminated | A Phase II Study of Paclitaxel and Carboplatin in Patients With an Elevated-Risk Cancer of the Uterus NCT00584909 | University of Alabama at Birmingham | Phase 2 |
| Completed | The RECHARGE Low Carbohydrate Diet Trial for Metastatic Cancer NCT00444054 | Albert Einstein College of Medicine | N/A |
| Terminated | Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinom NCT00582205 | University of Oklahoma | Phase 2 |
| Completed | Safety of Antioxidants During GYN Cancer Care NCT00284427 | Jeanne Drisko, MD, CNS, FACN | Phase 2 |
| Completed | Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the I NCT00588276 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Study of D-Methadone in Patients With Chronic Pain NCT00588640 | Memorial Sloan Kettering Cancer Center | Phase 1 / Phase 2 |
| Completed | Uterine Papillary Serous Cancer (UPSC) Trial NCT00147680 | Queensland Centre for Gynaecological Cancer | Phase 2 |
| Completed | A Phase II Study of Therapy With Paclitaxel, Carboplatin and Megesterol Acetate for the Management of Uterine NCT00584857 | University of Alabama at Birmingham | Phase 2 |
| Terminated | Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma NCT00506779 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Completed | Effectiveness of an Individualized Symptom Education Program (ISEP) NCT00275353 | University of Toronto | Phase 2 |
| Terminated | A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers NCT00231829 | Mark H. Einstein | Phase 2 |
| Completed | Intensity Modulated Radiotherapy (IMRT) for the Pelvis Post-Hysterectomy NCT00508703 | M.D. Anderson Cancer Center | — |
| Completed | Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus NCT00231842 | Montefiore Medical Center | Phase 2 |
| Completed | A Study of Radiation Therapy and Paclitaxel and Carboplatin in Patients With Uterine Papillary Serous Carcinom NCT00231868 | Montefiore Medical Center | Phase 2 |
| Completed | Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus NCT00614835 | Memorial Sloan Kettering Cancer Center | N/A |
| Withdrawn | Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have Cancer NCT00588263 | Memorial Sloan Kettering Cancer Center | — |
| Withdrawn | High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection NCT02095847 | M.D. Anderson Cancer Center | Phase 2 |
| No Longer Available | Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors NCT04681248 | Leap Therapeutics, Inc. | — |
| Temporarily Not Available | Expanded Access of Vigil in Solid Tumors NCT03842865 | Gradalis, Inc. | — |